DEADLINE: Monday, January 7, 2019, 5:00PM PT - **Extended to Friday, January 11, 12:00PM PT**
A key goal of the Stanford Maternal and Child Health Research Institute (MCHRI) is to provide early-career development and enhance the Stanford translational medicine community. We have partnered with the Eureka Institute for Translational Medicine to provide our maternal and child health community additional professional development through the Eureka International Certificate Program in Translational Medicine.
As a partner of the Eureka Institute for Translational Medicine, MCHRI is sponsoring four (4) MCHRI funded awardees to attend the 11th annual intensive 8-day certificate course on translational medicine which will be held in Siracusa, Sicily, from April 7 to April 13, 2019. This opportunity is open to all current instructors, assistant, and associate professors who have been funded by MCHRI.
The cost of the course registration fee (approx. $4,021) and 8-day lodging will be covered MCHRI. The Selected attendee’s department will be responsible for the cost of airfare and any incidentals. [The registration fee includes course materials, all lunches, breaks, and transportation from and to the Catania International Airport.]
Eligibility and Selection
All current MCHRI funded instructors, assistant, and associate professors are eligible to apply for the Eureka course only through the following internal RFA process:
- Submit (1) a maximum of one page Personal Statement describing why you believe that the course would be useful for the development of your career in clinical translational medicine and (2) current CV to MCHRI administration at email@example.com by Monday, January 7, 2019, 5:00PM PT. **EXTENDED TO FRIDAY, JANUARY 11, 2019, 12:00PM PT**
Four applicants will be selected and notified by Friday, January 18, 2019. Selected applicants will be required to submit a Letter of Support from their supervisor, along with the Personal Statement and CV, to the Eureka online application portal no later than January 27th. Applicants must be able to commit to the entire 8-day course and be relieved from all clinical/lab duties. The supervisor letter must commit to covering airfare and to ensuring the applicant is able to attend the full 8-day course.
Selection Priorities: candidates with the greater degree of sophistication in their understanding of what translational research means and who are in the best position to use the knowledge that they will acquire at the course to advance their research programs and career development.
- Applications that convincingly articulate how the course will influence the candidate’s career development
- Applications that specifically articulate the candidate’s anticipation of their future translational medicine leadership role within the Partner institute
- Applications that clearly articulate the candidate’s expectations of the course
About Eureka Institute
The mission of the Eureka Institute is to develop a community of translational medicine professionals equipped to catalyze the application of discoveries for the benefit of human health.
The Eureka Institute for Translational Medicine was established in 2008 by leaders in the field and incorporated in Italy with the legal status of a not-for-profit organization. In 2009, Eureka initiated an annual intense innovative 8-day certificate course on translational medicine with the goals of exposing talented young people to the challenges and opportunities of Translational Medicine in an international setting.
The course is offered to a maximum of 30 translational medicine professionals at various stages of career development in both Academia and Industry. The curriculum is delivered by experts from academia, industry, government-supported regulatory agencies (FDA, EMEA), venture capital and intellectual property law, as well as patient organizations.
The program is designed to build skills to foster innovative teams, critical thinking, and problem solving. The ultimate goal of this endeavor is to produce multidimensional, interdisciplinary professionals who are prepared for a wide range of careers focusing on improving human health.
Starting 2019, this course will focus on teaching and developing leaders, aimed at creating a cohort of translational medicine faculty for the partner. The attendees will be individuals who have the ability, resources and interest to contribute long term to the development of translational medicine teaching at the Partner, and to cooperation between the Partner and Eureka.
For more information on Eureka please visit the links below:
Please contact MCHRI Administration or 650-724-6891 with any questions.